The invention relates to medical devices, such as endoprostheses, and methods of making the devices.
The body includes various passageways such as arteries, other blood vessels, and other body lumens. These passageways sometimes become occluded or weakened. For example, the passageways can be occluded by a tumor, restricted by plaque, or weakened by an aneurysm. When this occurs, the passageway can be reopened or reinforced, or even replaced, with a medical endoprosthesis. An endoprosthesis is typically a tubular member that is placed in a lumen in the body. Endoprostheses can be delivered inside the body by a catheter that supports the endoprosthesis in a compacted or reduced-size form as the endoprosthesis is transported to a desired site. Upon reaching the site, the endoprosthesis is expanded, for example, so that it can contact the walls of the lumen.
The expansion mechanism may include forcing the endoprosthesis to expand radially. For example, the expansion mechanism can include the catheter carrying a balloon, which carries a balloon-expandable endoprosthesis. The balloon can be inflated to deform and to fix the expanded endoprosthesis at a predetermined position in contact with the lumen wall. The balloon can then be deflated, and the catheter withdrawn.
In another delivery technique, the endoprosthesis is formed of an elastic material that can be reversibly compacted and expanded, e.g., elastically or through a material phase transition. During introduction into the body, the endoprosthesis is restrained in a radially compacted condition. Upon reaching the desired implantation site, the restraint is removed, for example, by retracting a restraining device such as an outer sheath, enabling the endoprosthesis to self-expand by its own internal elastic restoring force.
The invention relates to medical devices, such as endoprostheses, and methods of making the devices. Exemplary endoprostheses include stents, covered stents, and stent-grafts.
In some embodiments, an endoprosthesis includes a deposited metallic film defining first and second opposed surfaces and a thickness of less than about 50 μm therebetween and at least one metal filament. The at least one filament defines a length. At least a portion of the filament along its length is embedded within the deposited metallic film between its first and second surfaces.
The deposited metallic film may include deposited titanium and nickel, e.g., an alloy including nickel and titanium.
The deposited film may have a substantially tubular shape defining a longitudinal axis. The at least one filament may extend, e.g., linearly or helically, generally along the longitudinal axis.
The tubular shape of the film may define a length along the longitudinal axis and the length of the filament may be at least about 30% of the length of the tubular shape of the film.
The endoprosthesis may include a plurality of filaments each defining a length. At least a portion of each wire along its length may be embedded within the metallic film between the first and second surfaces. Each filament may extend generally along the longitudinal axis. The length of each filament may be at least 30% of the length of the tubular shape of the film.
At least 75% of the filament along its length may be embedded within the metallic film between the first and second surfaces of the metallic film.
The filament, along its length, may include a plurality of embedded portions and at least one non-embedded portion. Each embedded portion may be embedded within the metallic film between the first and second surfaces of the metallic film. Adjacent embedded portions may be spaced apart by a non-embedded portion of the filament.
The substantially tubular shape may define a circumference. The at least one filament may extend at least partially about the circumference.
The at least one filament may be an alloy comprising nickel and titanium.
The metallic film and the at least one filament may each have a respective tensile strength, with the tensile strength of the filament being greater than the tensile strength of the metallic film. The metallic film and the at least one filament may each have a respective, different shape set configuration.
The endoprosthesis may include a stent body. The stent body and the deposited film may be generally concentric.
In some embodiments, an endoprosthesis includes a cover including at least one deposited metallic film. The cover defines first and second opposed metallic film edges. The first and second opposed metallic film edges each define a channel. At least one filament may extend along the channel of each opposed metallic film edge.
The deposited metallic film may include deposited nickel and titanium, e.g., an alloy including nickel and titanium.
The cover may have a substantially tubular shape defining a longitudinal axis. The at least one filament may extend generally parallel to the longitudinal axis. The tubular shape may define a length along the longitudinal axis. The length of the filament may be at least about 30% of the length of the tubular shape.
The first and second opposed edges may each define at least one offset tab. The channel of each opposed edge may be formed by the offset tab.
The first and second opposed edges may each define a plurality of channels. Each channel may be formed by a respective offset tab. The filament may extend through at least some of the channels of each opposed edge.
The endoprosthesis may include a stent body. At least a portion of the at least one filament and at least a portion of the stent body may be secured together.
The filament may define a longitudinal axis. An engagement between at least one of the channels and the filament may restrict movement of the filament along its longitudinal axis with respect to the at least one of the channels. The filament may have freedom of movement along its length with respect to at least one of the channels.
The first and second opposed edges may be a first pair of opposed edges and metallic film of the cover may define a plurality of pairs of first and second opposed edges. Each edge of each pair may define at least one channel. A respective filament may extend through the channel of each opposed edge of each pair. Each pair of opposed edges may extend generally along the longitudinal axis. Each filament may have a length at least about 30% of the length of the tubular shape. The first and second edges of each pair of opposed edges may have at least some relative freedom of movement with respect to a circumference of the cover.
In one aspect, the invention features an endoprosthesis including a metallic film, e.g., a vapor deposited film, including nickel, titanium, and chromium. A ratio of a weight of chromium of the metallic film to a combined weight of nickel, titanium, and chromium of the metallic film is at least 0.001 and can be less than 0.0075.
Other aspects, features, and advantages of the invention will be apparent from the description of the preferred embodiments thereof and from the claims.
a is a side view of a distal portion of a deployment device prior to radial expansion of the endoprosthesis.
b is a side view of the distal portion of the deployment device subsequent to radial expansion of the endoprosthesis adjacent the aneurysm.
a is a perspective view of an endoprosthesis.
b is a cross-sectional view of the endoprosthesis of
a is a cross-sectional end view of the cover of
b is the cover of
a shows an endoprosthesis having a plurality of integral, longitudinally extending filaments.
b is a cross-sectional view of the endoprosthesis of
Referring to
The endoprosthesis 100 modifies an amount or velocity of blood passing between vessel 26 and aneurysm 25. For example, prosthesis 100 can be deployed to reduce or block blood flow between vessel 26 and aneurysm 25. The endoprosthesis can also reduce blood flow from a feeder vessel 27. If so deployed, prosthesis 100 may sufficiently reduce blood flow to allow clotting or other healing processes to take place within aneurysm 25 and/or opening 29. Tubular member 54 can provide a greater attenuation of the blood flow into the aneurysm 25 than stent body 52 alone. Endoprosthesis 100, however, can allow some flow to pass between vessel 26 and aneurysm 25 even while providing some reduction in the rate and/or volume of flow. Prosthesis 100 can also (or alternatively) allow blood to pass between vessel 26 containing the prosthesis and adjacent vessels, e.g., feeder vessel 27, while still providing reduced flow with respect to the aneurysm.
Referring to
Referring particularly to
Upon expansion, endoprosthesis 100 assumes a shape and radial extent generally coextensive with an inner surface of the vessel 26, e.g., a tubular shape centered about a longitudinal axis a1 of the prosthesis (
The cover can be fixed to the stent by, e.g. fasteners. Attachment techniques include brazing, welding or attachment with a filament, rivets or grommets, or crimping, or adhesive. In some embodiments, the tubular member differs from a fabric at least in that the tubular member lacks fibers that can be pushed apart to receive a filament as by sewing a fabric. Accordingly, the fenestrations can be formed prior to the process of passing the filament through the tubular member. Fenestrations that receive the filaments can be formed by, e.g., etching, laser cutting, or a photolithographic process. Attachment techniques are described in U.S. Ser. No. 11/025,866, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, filed contemporaneously herewith, which application is incorporated herein by reference.
The cover is formed of a thin film that exhibits advantageous properties such as strength, toughness, and flexibility by selection of the composition of the film, processing techniques, and mechanical configuration. For example, in particular embodiments, the film is a vapor-deposited material composed of a nickel-titanium alloy having a strength additive, e.g. chromium. The film has a thickness of about 50 μm or less, e.g. about 4-35 μm, and includes fine fenestrations, which facilitate collapsing the film to small diameter for delivery into the body and expansion at the treatment site, while impeding blood access to the aneurysm. In particular embodiments, the film is processed to modify dislocations, which contribute to strength and toughness of the thin film.
Deposited materials are formed by depositing film constituents from a suspended state, e.g. in a vapor or a vacuum onto a surface. In embodiments, the constituents are suspended, e.g. by bombarding, heating or sputtering a bulk target. The suspended constituents deposit on a substrate to form the film. Deposited films can exhibit highly uniform thickness and microstructure in very thin films, e.g. about 50 μm or less, e.g. 4-35 μm. Deposition techniques include sputter deposition, pulsed laser deposition, ion beam deposition and plasma deposition. Suitable deposition processes are described in Busch et al. U.S. Pat. No. 5,061,914, Bose et al. U.S. Pat. No. 6,605,111, Johnston U.S. Pat. No. 6,533,905, and Gupta et al. U.S. 2004/0014253, the entire contents of all of which are hereby incorporated by reference.
In particular embodiments, the deposited film is an alloy that includes nickel and titanium, and a strength additive or additives, which modify a mechanical property, e.g., a hardness or elasticity, of the film. In particular embodiments, the film is a tertiary alloy that has substantially no other components besides nickel, titanium, and additive present in an amount greater than 1%, 0.5% or 0.2% or less than 20%, 10%, or 5% by weight of the film. The film may consist essentially of nickel, titanium, and chromium. In embodiments, the deposited film includes between 54 and 57 weight percent nickel with the balance composed essentially of titanium and chromium. In some embodiments, a ratio of a weight of chromium of the film to a combined weight of nickel, titanium, and chromium of the film is at least 0.001, at least 0.002 e.g., at least 0.0025. The ratio of the weight of chromium of the film to the combined weight of chromium, nickel, and titanium of the film can be 0.02 or less, 0.01 or less, e.g., 0.0075 or less. The ratio of the weight of chromium to the combined weight of chromium, nickel, and titanium of the film can be about 0.0025. In embodiments, the alloy exhibits superelastic or pseudo-elastic properties. Superelastic or pseudo-elastic metal alloy, as described, for example, in Schetsky, L. McDonald, “Shape Memory Alloys,” Encyclopedia of Chemical Technology (3rd ed.), John Wiley & Sons, 1982, vol. 20. pp. 726-736; and commonly assigned U.S. Ser. No. 10/346,487, filed Jan. 17, 2003.
A metallic film can be combined with one or more filaments in an endoprosthesis cover. Because the filaments and film may have very different mechanical properties, e.g., elongation before break and tensile strengths, the filaments and film cooperate to lend the cover desirable mechanical properties, e.g., toughness along the circumferential, radial, and/or longitudinal dimensions. In embodiments, a filament secures portions of a film relative to other portions of the film such as to maintain the three-dimensional shape of the cover and/or to secure the film with respect to a stent body.
Referring to
Filament 160 can include, e.g., a suture, a polymer, a textile, or a metal, e.g., a metal wire formed of gold, platinum, stainless steel, or a shape memory metal, e.g., nitinol. A filament can include a combination of such materials, e.g., a composite. The filament can be braided and need not have a circular configuration, e.g., the filament can be ribbon shaped. The filament typically has a thickness or radial dimension of less than a thickness of the film. In embodiments, the member is a metal wire having a diameter of about 10 μm or less, about 8μ, e.g., about 5 μm or less.
The filament 160 can have a higher tensile strength than the film of the cover 154. In embodiments, a ratio of the tensile strength of the filament 160 to the tensile strength of the film is at least about 1.5, e.g., at least about 2. The ratio may be about 4 or less, e.g., about 3 or less. The filament may be a nitinol wire having a tensile strength of at least 200 ksi, at least 250 ksi, e.g., at least 300 ksi. An exemplary metallic film has a tensile strength of 150 ksi.
In some embodiments, the filament 160 includes a wire of shape memory metal that is shape set differently from a shape set of the metallic film. In some embodiments, one of the member 160 and metallic film is shape set at a configuration corresponding to the radially compressed state within a delivery device while the other of the member and film is shape set at a configuration corresponding to the radially expanded state within a body passage. A primary difference in the shape set between the member 160 and the cover may be in the shape set length, with one of the member and cover having a longer shape set length than the other.
An exemplary method of manufacturing cover 154 includes depositing a metallic film on a substrate. The cover can be provided with fenestrations 62, which are not shown in
Adjacent tabs 156i are relatively secured by filament 160. The filament 160 can be inserted along the common axis of channels 158i or inserted laterally through a terminal gap Δg of each tab. If present, the terminal gap of each tab can be closed after introducing member 160. Either before or after positioning filament 160 with respect to tabs 156i, film 154 can be disposed with respect to a stent body, e.g., about the stent body (
In some embodiments, filament 160 and some or all of tabs 156i have little or no relative freedom of movement. For example, each tab 156i may mechanically engage filament 160 via a tight fit between respective channel 158i and the member 160. An adhesive or other polymer may also or alternatively be used to enhance the engagement between the filament and the channels of the tabs.
In embodiments, filament 160 and some or all of channels 158i allow some relative freedom of movement, e.g., longitudinal or circumferential freedom of movement. During radial compression and expansion of an endoprosthesis, the cover 154 and filament 160 move relatively to accommodate different length changes without deforming the cover or endoprosthesis. Longitudinal freedom of movement may be provided by a filament not tightly engaged by the channels, e.g., by a filament having a diameter smaller than an inner diameter of the channels. Circumferential freedom of movement can be provided by circumferentially elongating the channels so that the cover edges 157,159 can move circumferentially relative to one another, e.g., toward and away from one another. Adjacent tabs 156i and 156i±1 may define gaps (not shown) to allow the cover edges some relative longitudinal freedom of movement. An elastic polymer may fill the channels to help retain the filament yet allow some relative movement.
Channels 158i are shown as extending coaxially the entire length of the cover. In some embodiments, channels 158i extend along only a portion of the cover length, e.g., ½ the length or less, ⅓ the length or less, or ¼ the length or less. The resulting “shorter” channel may be located anywhere along the length of the endoprosthesis, e.g., centrally or distally or proximally relative to an implanted prosthesis.
Channels 158i are shown as generally parallel with a longitudinal axis of the endoprosthesis 150. In embodiments, the channels 158i and filaments can have other configurations, e.g., circumferential, curved, or helical about the endoprosthesis.
Referring to
Referring to
Cover portions 177,179 may have some freedom of movement relative to one another. For example, by allowing longitudinal or circumferential freedom of movement between different cover portions, an endoprosthesis can accommodate delivery or deployment within a tortuous body passage having small radius curves. Freedom of movement between the cover portions can be provided using, e.g., the techniques described for providing relative freedom of movement between a filament and cover.
Referring to
An exemplary method of manufacturing cover 200 includes depositing a first layer of metallic film on a substrate, whether two- or three-dimensional. A sacrificial medium, e.g., chromium, is photolithographically deposited over portions of the previously deposited film.
The sacrificial medium is formed of a material, e.g., chromium, that can be removed, e.g., by etching, from the metallic film without damage thereto. Additional material of the metallic film is deposited over the sacrificial medium to complete the film. Subsequently, the sacrificial medium is removed from the remaining film leaving behind the integral channels.
Referring to
An exemplary method for forming cover 300 includes depositing a first layer of metallic film. Wires 160 are positioned adjacent the deposited film. Additional metal is deposited over the wires to integrate the wires and film. In an alternative method, wires 160 are positioned over a substrate. A first amount of metallic film is deposited over the wires and substrate. Subsequently, the first amount of film and substrate are separated and additional metal film is deposited to integrate the wires and film.
Referring to
In some embodiments, a deposited thin film and including one or more filaments is useable as an endoprosthesis without a supporting stent. For example, an endoprosthesis without a supporting stent can include a deposited thin film including one or more at least partially embedded wires contributing to radial and/or longitudinal strength of the film.
In some embodiments, the filaments, whether embedded or not, extend beyond an end of the endoprosthesis. The extending filaments can be used to, e.g., re-sheath the endoprosthesis in order to change its position or withdraw it from a lumen, or to pull the endoprosthesis along a body lumen.
In the embodiment shown, an endoprosthesis has a generally tubular shape. In some embodiments, however, the endoprosthesis (or stent body 52 or tubular member 54 individually) has or includes other shapes such as conical, oblate, and branched. The endoprosthesis may have a closed end to form, e.g., a basket shape. Thin films, discussed above, composed of Ni—Ti-strength additive alloys and/or with modified microstructures, can be used in other applications. Examples include baskets, filters, catheters, guidewires, and medical balloons, such as an angioplasty balloon. Filaments of such endoprostheses may intersect or be woven to define a shape of the endoprosthesis.
Other examples of endoprostheses including a thin film as well as related systems and methods are described in U.S. provisional patent application No. 60/549,287, filed Mar. 2, 2004, which application is incorporated herein by reference.
An endoprosthesis may include a cover disposed externally to a framework as shown and/or internally of a framework. Endoprostheses having a cover including, e.g., a deposited thin film, disposed internally of a framework are described in U.S. patent application Ser. No. 11/025,464, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.
An endoprosthesis may include features to enhance a flexibility of the endoprosthesis as described in U.S. patent application Ser. No. 11/025,158, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.
The composition and/or fabrication method of a deposited thin film of an endoprosthesis may include features that enhance a strength or toughness of the film as described in U.S. patent application Ser. No. 11/025,860, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.
An endoprosthesis may include a deposited thin film and a polymer as described in U.S. patent application Ser. No. 11/025,867, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.
Methods for loading an endoprosthesis into a delivery device and systems for delivering an endoprosthesis to a treatment site are described in U.S. patent application Ser. No. 11/025,660, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR LOADING AND DEPLOYING SAME, which application is incorporated herein by reference.
All publications, references, applications, and patents referred to herein are incorporated by reference in their entirety.
Other embodiments are within the claims.
This application is a continuation of U.S. patent application Ser. No. 11/025,684, filed Dec. 29, 2004. The disclosure of the prior application is hereby incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
4793348 | Palmaz | Dec 1988 | A |
4864824 | Gabriel et al. | Sep 1989 | A |
5035706 | Giantureo et al. | Jul 1991 | A |
5061914 | Busch et al. | Oct 1991 | A |
5085535 | Solberg et al. | Feb 1992 | A |
5119555 | Johnson | Jun 1992 | A |
5245738 | Johnson | Sep 1993 | A |
5302261 | LeRoy et al. | Apr 1994 | A |
5306294 | Winston et al. | Apr 1994 | A |
5325880 | Johnson et al. | Jul 1994 | A |
5382261 | Palmaz | Jan 1995 | A |
5405378 | Strecker et al. | Apr 1995 | A |
5441515 | Khosravi et al. | Aug 1995 | A |
5518680 | Cima et al. | May 1996 | A |
5554182 | Dinh et al. | Sep 1996 | A |
5556413 | Lam | Sep 1996 | A |
5607466 | Imbert et al. | Mar 1997 | A |
5619177 | Johnson et al. | Apr 1997 | A |
5656036 | Palmaz | Aug 1997 | A |
5667523 | Bynon et al. | Sep 1997 | A |
5674242 | Phan et al. | Oct 1997 | A |
5676697 | McDonald | Oct 1997 | A |
5728150 | McDonald et al. | Mar 1998 | A |
5755734 | Richter et al. | May 1998 | A |
5800517 | Anderson et al. | Sep 1998 | A |
5817102 | Johnson et al. | Oct 1998 | A |
5824042 | Lombardi et al. | Oct 1998 | A |
5824049 | Ragheb et al. | Oct 1998 | A |
5824054 | Khosravi et al. | Oct 1998 | A |
RE35988 | Winston et al. | Dec 1998 | E |
5843158 | Lenker et al. | Dec 1998 | A |
5843164 | Frantzen et al. | Dec 1998 | A |
5843289 | Lee et al. | Dec 1998 | A |
5849206 | Amon et al. | Dec 1998 | A |
5860998 | Robinson et al. | Jan 1999 | A |
5865723 | Love | Feb 1999 | A |
5882444 | Flomenblit et al. | Mar 1999 | A |
5888734 | Cremer et al. | Mar 1999 | A |
5897911 | Loeffler | Apr 1999 | A |
5903099 | Johnson et al. | May 1999 | A |
5938697 | Killion et al. | Aug 1999 | A |
5941249 | Maynard | Aug 1999 | A |
5957929 | Brenneman | Sep 1999 | A |
5984963 | Ryan et al. | Nov 1999 | A |
6007573 | Wallace et al. | Dec 1999 | A |
6015431 | Thornton et al. | Jan 2000 | A |
6015433 | Roth | Jan 2000 | A |
6017977 | Evans et al. | Jan 2000 | A |
6036725 | Avellanet | Mar 2000 | A |
6043451 | Julien et al. | Mar 2000 | A |
6048622 | Hagood et al. | Apr 2000 | A |
6059766 | Greff | May 2000 | A |
6077298 | Tu et al. | Jun 2000 | A |
6096175 | Roth | Aug 2000 | A |
6099561 | Alt | Aug 2000 | A |
6107004 | Donadio, III | Aug 2000 | A |
6120535 | McDonald et al. | Sep 2000 | A |
6132460 | Thompson | Oct 2000 | A |
6133547 | Maynard | Oct 2000 | A |
6139564 | Teoh | Oct 2000 | A |
6143022 | Shull et al. | Nov 2000 | A |
6159239 | Greenhalgh | Dec 2000 | A |
6174330 | Stinson | Jan 2001 | B1 |
6190404 | Palmaz et al. | Feb 2001 | B1 |
6206911 | Milo | Mar 2001 | B1 |
6224627 | Armstrong et al. | May 2001 | B1 |
6224630 | Bao et al. | May 2001 | B1 |
6245104 | Alt | Jun 2001 | B1 |
6254628 | Wallace et al. | Jul 2001 | B1 |
6258117 | Camrud et al. | Jul 2001 | B1 |
6290720 | Khosravi et al. | Sep 2001 | B1 |
6303100 | Ricci et al. | Oct 2001 | B1 |
6315788 | Roby | Nov 2001 | B1 |
6315794 | Richter | Nov 2001 | B1 |
6355055 | Waksman et al. | Mar 2002 | B1 |
6379383 | Palmaz et al. | Apr 2002 | B1 |
6398803 | Layne et al. | Jun 2002 | B1 |
6406487 | Brenneman | Jun 2002 | B2 |
6406490 | Roth | Jun 2002 | B1 |
6409749 | Maynard | Jun 2002 | B1 |
6428569 | Brown | Aug 2002 | B1 |
6447478 | Maynard | Sep 2002 | B1 |
6454738 | Tran et al. | Sep 2002 | B1 |
6458152 | Khosravi et al. | Oct 2002 | B1 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6471980 | Sirhan et al. | Oct 2002 | B2 |
6485510 | Camrud et al. | Nov 2002 | B1 |
6506211 | Skubitz et al. | Jan 2003 | B1 |
6520984 | Garrison et al. | Feb 2003 | B1 |
6527919 | Roth | Mar 2003 | B1 |
6533905 | Johnson et al. | Mar 2003 | B2 |
6537310 | Palmaz et al. | Mar 2003 | B1 |
6605111 | Bose et al. | Aug 2003 | B2 |
6614570 | Johnson et al. | Sep 2003 | B2 |
6618921 | Thornton | Sep 2003 | B1 |
6620192 | Jalisi | Sep 2003 | B1 |
6620634 | Johnson et al. | Sep 2003 | B2 |
6624730 | Johnson et al. | Sep 2003 | B2 |
6629993 | Voinov | Oct 2003 | B2 |
6632240 | Khosravi et al. | Oct 2003 | B2 |
6638301 | Chandrasekaran et al. | Oct 2003 | B1 |
6666882 | Bose et al. | Dec 2003 | B1 |
6669719 | Wallace et al. | Dec 2003 | B2 |
6669721 | Bose et al. | Dec 2003 | B1 |
6669795 | Johnson et al. | Dec 2003 | B2 |
6673102 | Vonesh et al. | Jan 2004 | B1 |
6676987 | Zhong et al. | Jan 2004 | B2 |
6695865 | Boyle et al. | Feb 2004 | B2 |
6699278 | Fischell et al. | Mar 2004 | B2 |
6699279 | Stevens et al. | Mar 2004 | B2 |
6746478 | Jayaraman | Jun 2004 | B2 |
6752826 | Holloway et al. | Jun 2004 | B2 |
6767418 | Zhang et al. | Jul 2004 | B1 |
6776795 | Pelton | Aug 2004 | B2 |
6820676 | Palmaz et al. | Nov 2004 | B2 |
6849085 | Marton | Feb 2005 | B2 |
6936066 | Palmaz et al. | Aug 2005 | B2 |
6953560 | Castro et al. | Oct 2005 | B1 |
7105018 | Yip et al. | Sep 2006 | B1 |
7279175 | Chen et al. | Oct 2007 | B2 |
7410497 | Hastings et al. | Aug 2008 | B2 |
7632303 | Stalker et al. | Dec 2009 | B1 |
7901447 | Molaei et al. | Mar 2011 | B2 |
7947071 | Schmid et al. | May 2011 | B2 |
20010001834 | Palmaz et al. | May 2001 | A1 |
20010032013 | Marton | Oct 2001 | A1 |
20010039449 | Johnson et al. | Nov 2001 | A1 |
20010044647 | Pinchuk et al. | Nov 2001 | A1 |
20020007958 | Rivelli et al. | Jan 2002 | A1 |
20020017503 | Banas et al. | Feb 2002 | A1 |
20020019662 | Brauckman et al. | Feb 2002 | A1 |
20020035774 | Austin | Mar 2002 | A1 |
20020042645 | Shannon | Apr 2002 | A1 |
20020046783 | Johnson et al. | Apr 2002 | A1 |
20020142119 | Seward et al. | Oct 2002 | A1 |
20020151965 | Roth | Oct 2002 | A1 |
20020161342 | Rivelli, Jr. et al. | Oct 2002 | A1 |
20020162605 | Horton et al. | Nov 2002 | A1 |
20020165576 | Boyle et al. | Nov 2002 | A1 |
20020165600 | Banas et al. | Nov 2002 | A1 |
20020173809 | Fleischman et al. | Nov 2002 | A1 |
20020187288 | Lim et al. | Dec 2002 | A1 |
20020193869 | Dang | Dec 2002 | A1 |
20020195579 | Johnson | Dec 2002 | A1 |
20020198584 | Unsworth et al. | Dec 2002 | A1 |
20030002994 | Johnson et al. | Jan 2003 | A1 |
20030004567 | Boyle et al. | Jan 2003 | A1 |
20030018354 | Roth et al. | Jan 2003 | A1 |
20030023303 | Palmaz et al. | Jan 2003 | A1 |
20030040791 | Oktay | Feb 2003 | A1 |
20030050691 | Shifrin et al. | Mar 2003 | A1 |
20030059640 | Marton et al. | Mar 2003 | A1 |
20030060782 | Bose et al. | Mar 2003 | A1 |
20030074049 | Hoganson et al. | Apr 2003 | A1 |
20030078649 | Camrud et al. | Apr 2003 | A1 |
20030083731 | Kramer et al. | May 2003 | A1 |
20030127318 | Johnson et al. | Jul 2003 | A1 |
20030130718 | Palmas et al. | Jul 2003 | A1 |
20030130721 | Martin et al. | Jul 2003 | A1 |
20030139797 | Johnson et al. | Jul 2003 | A1 |
20030153971 | Chandrasekaran | Aug 2003 | A1 |
20030159920 | Roth | Aug 2003 | A1 |
20030185895 | Lanphere et al. | Oct 2003 | A1 |
20030187495 | Cully et al. | Oct 2003 | A1 |
20030212430 | Bose et al. | Nov 2003 | A1 |
20040006381 | Sequin et al. | Jan 2004 | A1 |
20040014253 | Gupta et al. | Jan 2004 | A1 |
20040030377 | Dubson et al. | Feb 2004 | A1 |
20040034408 | Majercak et al. | Feb 2004 | A1 |
20040054399 | Roth et al. | Mar 2004 | A1 |
20040054406 | Dubson et al. | Mar 2004 | A1 |
20040059410 | Cox | Mar 2004 | A1 |
20040098095 | Burnside et al. | May 2004 | A1 |
20040107004 | Levine et al. | Jun 2004 | A1 |
20040143317 | Stinson et al. | Jul 2004 | A1 |
20040199239 | Austin et al. | Oct 2004 | A1 |
20040225350 | Shanley | Nov 2004 | A1 |
20040254520 | Porteous et al. | Dec 2004 | A1 |
20050004653 | Gerberding et al. | Jan 2005 | A1 |
20050010275 | Sahatjian et al. | Jan 2005 | A1 |
20050033399 | Richter | Feb 2005 | A1 |
20050165468 | Marton | Jul 2005 | A1 |
20050165469 | Hogendijk | Jul 2005 | A1 |
20050197687 | Molaei et al. | Sep 2005 | A1 |
20050197689 | Molaei et al. | Sep 2005 | A1 |
20050197690 | Molaei et al. | Sep 2005 | A1 |
20060069428 | Feller | Mar 2006 | A1 |
20060100659 | Dinh et al. | May 2006 | A1 |
20060115514 | Gengrinovitch | Jun 2006 | A1 |
20060122691 | Richter | Jun 2006 | A1 |
20060142838 | Molaei et al. | Jun 2006 | A1 |
20060142842 | Molaei et al. | Jun 2006 | A1 |
20060142845 | Molaei et al. | Jun 2006 | A1 |
20060142851 | Molaei et al. | Jun 2006 | A1 |
20060147492 | Hunter et al. | Jul 2006 | A1 |
20060184231 | Rucker | Aug 2006 | A1 |
20060259131 | Molaei et al. | Nov 2006 | A1 |
20060271158 | Olson | Nov 2006 | A1 |
20070016283 | Greenhalgh et al. | Jan 2007 | A1 |
20070073385 | Schaeffer et al. | Mar 2007 | A1 |
20070112411 | Obermiller et al. | May 2007 | A1 |
20070250156 | Palmaz | Oct 2007 | A1 |
20080027388 | Banas et al. | Jan 2008 | A1 |
20080221665 | Peckham et al. | Sep 2008 | A1 |
20090132022 | Banas | May 2009 | A1 |
20090187240 | Clerc et al. | Jul 2009 | A1 |
20100030320 | Feller, III | Feb 2010 | A1 |
20110054590 | Leopold et al. | Mar 2011 | A1 |
Number | Date | Country |
---|---|---|
0 472 731 | Aug 1991 | EP |
0 792 627 | Sep 1997 | EP |
1 604 697 | Dec 2005 | EP |
1 725 186 | Nov 2006 | EP |
1 725 187 | Nov 2006 | EP |
1 725 188 | Nov 2006 | EP |
2 125 442 | Mar 1984 | GB |
2003102849 | Aug 2003 | JP |
2007502069 | Sep 2007 | JP |
2007526098 | Sep 2007 | JP |
2007526099 | Sep 2007 | JP |
WO 9606814 | Mar 1996 | WO |
WO 9853362 | Nov 1998 | WO |
WO 9902092 | Jan 1999 | WO |
WO 9960267 | Dec 1999 | WO |
WO 9962432 | Dec 1999 | WO |
WO 0062711 | Oct 2000 | WO |
WO 0121097 | Mar 2001 | WO |
WO 0153559 | Jul 2001 | WO |
WO 0187371 | Nov 2001 | WO |
WO 0189420 | Nov 2001 | WO |
WO 0191823 | Dec 2001 | WO |
WO 0195697 | Dec 2001 | WO |
WO 0234163 | May 2002 | WO |
WO 0238080 | May 2002 | WO |
WO 0238086 | May 2002 | WO |
WO 02060506 | Aug 2002 | WO |
WO 03003943 | Jan 2003 | WO |
WO 03011363 | Feb 2003 | WO |
WO 03013337 | Feb 2003 | WO |
WO 03015840 | Feb 2003 | WO |
WO 03018100 | Mar 2003 | WO |
WO 03075793 | Sep 2003 | WO |
WO 03075799 | Sep 2003 | WO |
WO 03099161 | Dec 2003 | WO |
WO 2004002370 | Jan 2004 | WO |
WO 2004008504 | Jan 2004 | WO |
WO 2004028340 | Apr 2004 | WO |
2005084583 | Sep 2005 | WO |
2005084584 | Sep 2005 | WO |
2005084585 | Sep 2005 | WO |
2006125022 | Apr 2006 | WO |
2006071215 | Jul 2006 | WO |
2006071242 | Jul 2006 | WO |
2006071243 | Jul 2006 | WO |
2006071244 | Jul 2006 | WO |
2006071245 | Jul 2006 | WO |
Entry |
---|
0566WO1 ISR—PCT/US2005/007282 mailed Jul. 5, 2005, 15 pages. |
0567WO1 ISR—PCT/US2005/006993 mailed Aug. 2, 2005, 21 pages. |
0568WO1 ISR—PCT/US2005/007161 mailed Jul. 28, 2005, 45 pages. |
0569WO1 ISR—PCT/US2005/007173 mailed Dec. 6, 2005, 19 pages. |
0570WO1 ISR—PCT/US2005/007164 mailed Jul. 5, 2005, 13 pages. |
0596WO1 ISR—PCT/US2005/007162 mailed Oct. 4, 2005, 16 pages. |
0621WO1 ISR—PCT/US2005/006895 mailed Mar. 2, 2005, 16 pages. |
0627WO1 ISR—PCT/US2006/019126 mailed Feb. 1, 2007, 16 pages. |
Dieter, George, Mechanical Metallurgy, Singapore, McGraw-Hill Book Co., 10th Printing 1984, pp. 111-117, 142-145, and 234-237. TA405.D53. |
Freiherr, Greg, “Shape-Memory Alloys Offer Untapped”, Medical Device & Diagnostic Industry Magazine, Mar. 1998, 5 pages [retrieved on Jun. 30, 2004]. |
Fu et al., “TiNi-based thin films in MEMS applications: a review”, Sensors and Actuators, Article in Press, Elsevier, Feb. 2004, 14 pages. |
Gertner et al., “Drug Delivery from Electrochemically Deposited Thin Metal Films”, Electrochemical and Sold-State Letter, 6 (4) J4-J6, 2003. |
Gertner et al., “Electrochemistry and Medical Devices: Friend or Foe?”, The Electrochemical Society Interface, Fall 2003, pp. 20-24. |
Gupta et al., “Nitinol Thin Film Three-Dimensional Devices—Fabrication and Applications”, http://www.tinialloy.com/pdf/smst.pdf, Sep. 7, 2003 [retrieved Dec. 1, 2004]. |
He et al., “CO2 laser annealing of sputtering deposited NiTi shape memory thin films”, Journal of Micromechanics and Microengineering, May 20, 2004, pp. 950-956. |
Kaczmarek, S. M., “Pulsed laser deposition—today and tomorrow”, STL'96, Proc. SPIE, vol. 3187, 1997, pp. 129-134. |
Krebs et al., “Pulsed Laser Deposition (PLD)—a Versatile Thin Film Technique”, Advances in Solid State Physics 2003, 43, 505-517. |
Nakayama et al., “Fabrication of micropored elastomeric film-covered stents and acute-phase performances”, Journal of Biomedical Mateirals Research Part A, vol. 64A, Issue 1, Sep. 30, 2002, pp. 52-61. |
Neocera, Inc. Brochure—Pulsed Laser Deposition, www.neocera.com [retrieved Dec. 1, 2004]. |
Padhi et al., “Planarization of Copper Thin Films by Electropolishing in Phosphoric Acid for ULSI Application”, Journal of Electrochemical Society, vol. 150, 2003, pp. G10-G14. |
Pelleiter et al., “Effect of high energy argon implantation into NiTi shape memory alloy”, Surface and Coatings Technology, 158-159, 2002, pp. 301-308. |
Ren et al., “Carbon nitride materials synthesized by Ion-assisted pulsed laser deposition”, Riken Review No. 43, Jan. 2002, pp. 41-44. |
Schetky et al., “Issues in the Further Development of Nitinol Properties and Processing for Medical Device Application”, Proceedings, ASM Materials & Processes for Medical Devices Conference, Anaheim, in press, 2003, 6 pages. |
Shabalovskaya et al., “Comparative performances of Nitinol surfaces in protein adsorption and platelet adhesion—Preliminary results”, Institute for Physical Research and Technology, Ames Laboratory, Ames, IA University of Washington, Seattle WA Memry Corporation, Bethel CT, 2004, 10 pages. |
Stoeckel et al., “A survey of stent designs”, Min Invas Ther & Allied Technol, 11(4), 2002, pp. 137-147. |
Number | Date | Country | |
---|---|---|---|
20110144740 A1 | Jun 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11025684 | Dec 2004 | US |
Child | 13031923 | US |